Company overview
ProtonDx develops portable point-of-care molecular diagnostic platforms like Dragonfly for rapid detection of viral and bacterial pathogens in human and animal health, delivering PCR-quality results in under 30 minutes without lab infrastructure. Their Research Use Only (RUO) products support customizable testing for diseases including COVID-19, malaria, mpox, influenza, and veterinary pathogens like APP and GPS. Solutions include isothermal amplification, nucleic acid extraction kits, and multiplex assays adaptable for life sciences research, agriculture, and global health applications.
ProtonDx is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include molecular diagnostics, point-of-care testing, pathogen detection, dragonfly platform, nucleic acid extraction.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.protondx.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- molecular diagnostics, point-of-care testing, pathogen detection, dragonfly platform, nucleic acid extraction
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What diagnostic platforms and capabilities does ProtonDx offer?
- ProtonDx offers the Dragonfly portable molecular diagnostic platform using isothermal amplification (LyoLAMP) for multiplex detection of up to six pathogens in under 30 minutes, plus SmartLid nucleic acid extraction kits for human, animal, and research applications.
- What regulatory status apply to ProtonDx products?
- Products are primarily Research Use Only (RUO) for research applications, with portable systems intended for use by trained operators, not self-testing; some assays support clinical decision-making in research settings.
- What geographies and sectors does ProtonDx serve?
- ProtonDx serves global markets including human health, animal agriculture, veterinary, life sciences, and food safety, with deployments in extreme conditions worldwide and partnerships for custom solutions in pharma, farms, and remote care.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
